NCT06184035View on ClinicalTrials.gov

A Dose Escalation and Expansion Study of [177Lu]Lu-SN201 in Participants With Advanced Cancer

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 30, 2023

Primary Completion Date

December 1, 2027

Study Completion Date

December 31, 2027

Conditions
Solid TumorMetastatic CancerUnresectable Solid TumorRecurrent Solid TumorLocally Advanced Solid TumorRefractory Cancer
Interventions
DRUG

[177Lu]Lu-SN201

Intravenous infusion

Trial Locations (2)

3065

NOT_YET_RECRUITING

St Vincent Hospital Melbourne, Melbourne

5000

RECRUITING

Cancer Research South Adelaide, Adelaide

All Listed Sponsors
lead

Spago Nanomedical AB

INDUSTRY